Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)
4.6000
-0.4500 (-8.91%)
NASDAQ · Last Trade: Apr 5th, 6:20 PM EDT

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 13, 2025

Via Benzinga · February 11, 2025

Via Benzinga · December 30, 2024

Via Benzinga · December 24, 2024

Via Benzinga · December 24, 2024

Via Benzinga · October 9, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via Benzinga · February 7, 2024

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a once-daily oral treatment.
Via Benzinga · September 26, 2024

ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via InvestorPlace · August 5, 2024

ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · May 6, 2024

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48.
Via Benzinga · November 21, 2023

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
Via Benzinga · November 20, 2023